Taking action for rare cancers

For many rare cancers patients, it can be difficult to have access to appropriate therapies and clinical expertise, due to the fact that there has been a limited number of clinical studies to find new drugs and treatments, writes Mihaela Militaru.

Mihaela Militaru is the director of the European Cancer Patient Coalition (ECPC).